TY  - JOUR
AU  - Blánquez-Martínez, David
AU  - Díaz-Villamarín, Xando
AU  - Antúnez-Rodríguez, Alba
AU  - Pozo-Agundo, Ana
AU  - Muñoz-Ávila, José Ignacio
AU  - Martínez-González, Luis Javier
AU  - Dávila-Fajardo, Cristina Lucía
PY  - 2021
DO  - 10.3390/pharmaceutics13111973
SN  - 1999-4923
UR  - https://hdl.handle.net/10668/26382
T2  - Pharmaceutics
AB  - High myopia is an ophthalmic pathology that affects half of the young adults in the United States and Europe and it is predicted that a third of the world's population could be nearsighted at the end of this decade. It is characterized by at least 6...
LA  - en
KW  - ARMS2
KW  - CFH
KW  - VEGFA
KW  - anti-VEGF
KW  - genetic polymorphism
KW  - myopia
KW  - personalized medicine
KW  - pharmacogenetic
KW  - ranibizumab
TI  - Genetic Polymorphisms Affecting Ranibizumab Response in High Myopia Patients.
TY  - research article
VL  - 13
ER  -